| abstract |
The present invention provides: a peptide that includes a partial amino acid sequence of the C16orf74 protein, includes the cysteine at position 7 and/or the cysteine at position 14 of the C16orf74 protein, and inhibits dimer formation of the C16orf74 protein; a pharmaceutical composition for cancer treatment that includes the peptide; and a screening method for cancer treatment drugs that takes as the indicator inhibition of dimer formation of the C16orf74 protein. |